BR9408530A - Intermediário e processo para preparação - Google Patents
Intermediário e processo para preparaçãoInfo
- Publication number
- BR9408530A BR9408530A BR9408530A BR9408530A BR9408530A BR 9408530 A BR9408530 A BR 9408530A BR 9408530 A BR9408530 A BR 9408530A BR 9408530 A BR9408530 A BR 9408530A BR 9408530 A BR9408530 A BR 9408530A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation process
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/190,630 US5461154A (en) | 1994-02-02 | 1994-02-02 | Intermediate and process for making |
| PCT/US1994/011352 WO1995021164A1 (en) | 1994-02-02 | 1994-10-06 | Intermediate and process for making |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9408530A true BR9408530A (pt) | 1997-08-05 |
Family
ID=22702137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9408530A BR9408530A (pt) | 1994-02-02 | 1994-10-06 | Intermediário e processo para preparação |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5461154A (pt) |
| EP (1) | EP0741719A4 (pt) |
| JP (1) | JPH09509657A (pt) |
| AU (1) | AU7930494A (pt) |
| BR (1) | BR9408530A (pt) |
| CA (1) | CA2180860A1 (pt) |
| HU (1) | HUT76285A (pt) |
| WO (1) | WO1995021164A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL110255A (en) * | 1993-07-16 | 1998-12-06 | Merck & Co Inc | Creation and resolution of 2 tert-butylcarboxamidopiprazine |
| WO1995014675A1 (fr) * | 1993-11-22 | 1995-06-01 | Koei Chemical Co., Ltd. | PROCEDE DE PRODUCTION DE N-tert-BUTYL-2-PYRAZINECARBOXAMIDE ET DE N-tert-BUTYL-2-PIPERAZINECARBOXAMIDE |
| US5767316A (en) | 1995-11-17 | 1998-06-16 | Ajinomoto Co., Inc. | Process for producing 3-amino-2-oxo-1-halogenopropane derivatives |
| CA2238337A1 (en) * | 1995-12-07 | 1997-06-12 | The Scripps Research Institute | Hiv protease inhibitors |
| DE19704885C1 (de) * | 1997-02-11 | 1998-06-10 | Clariant Gmbh | Verfahren zur Herstellung von 3-Hydroxy-2-methylbenzoesäure und 3-Acetoxy-2-methylbenzoesäure |
| DE19730602A1 (de) * | 1997-07-17 | 1999-01-21 | Clariant Gmbh | 3-Acetoxy-2-methylbenzoesäurechlorid und ein Verfahren zu seiner Herstellung |
| EP1910317B1 (en) | 2005-07-20 | 2013-07-03 | Eli Lilly And Company | 1-amino linked compounds |
| CN111108105B (zh) | 2017-09-22 | 2023-03-31 | 朱比兰特埃皮帕德有限公司 | 作为pad抑制剂的杂环化合物 |
| SG11202003463XA (en) | 2017-10-18 | 2020-05-28 | Jubilant Epipad LLC | Imidazo-pyridine compounds as pad inhibitors |
| CA3080677A1 (en) | 2017-11-06 | 2019-05-09 | Jubilant Prodel LLC | Pyrimidine derivatives as inhibitors of pd1/pd-l1 activation |
| IL274762B2 (en) | 2017-11-24 | 2023-10-01 | Jubilant Episcribe Llc | Novel heterocyclic compounds as PRMT5 inhibitors |
| SG11202008950PA (en) | 2018-03-13 | 2020-10-29 | Jubilant Prodel LLC | Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4191765A (en) * | 1976-05-25 | 1980-03-04 | Hoechst Aktiengesellschaft | 1-Aryloxy-2-hydroxy-3-aminopropanes |
| US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| MX9308016A (es) * | 1992-12-22 | 1994-08-31 | Lilly Co Eli | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. |
-
1994
- 1994-02-02 US US08/190,630 patent/US5461154A/en not_active Expired - Fee Related
- 1994-10-06 BR BR9408530A patent/BR9408530A/pt not_active Application Discontinuation
- 1994-10-06 EP EP94930064A patent/EP0741719A4/en not_active Withdrawn
- 1994-10-06 JP JP7520584A patent/JPH09509657A/ja active Pending
- 1994-10-06 WO PCT/US1994/011352 patent/WO1995021164A1/en not_active Application Discontinuation
- 1994-10-06 CA CA002180860A patent/CA2180860A1/en not_active Abandoned
- 1994-10-06 AU AU79304/94A patent/AU7930494A/en not_active Abandoned
- 1994-10-06 HU HU9602105A patent/HUT76285A/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995021164A1 (en) | 1995-08-10 |
| JPH09509657A (ja) | 1997-09-30 |
| EP0741719A4 (en) | 1997-04-02 |
| HU9602105D0 (en) | 1996-09-30 |
| EP0741719A1 (en) | 1996-11-13 |
| US5461154A (en) | 1995-10-24 |
| HUT76285A (en) | 1997-07-28 |
| CA2180860A1 (en) | 1995-08-10 |
| AU7930494A (en) | 1995-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9504561A (pt) | Processo de fabricaçao de restriçao e restriçao | |
| PT909327E (pt) | Eritromicinas e processo para a sua preparacao | |
| PT799866E (pt) | Negro-de-fumo e processo para a sua preparacao | |
| BR9507339A (pt) | Selo auto-aderente e processo para fabricação do mesmo | |
| BR9711020A (pt) | Composi-Æo aquosa de xanpu e processo para fabricar a composi-Æo aquosa de xampu | |
| BR9400475A (pt) | Processo de preparação de zeólita modificada e zeólita modificada | |
| BR9306520A (pt) | Processo e composição para limpeza | |
| BR9706247A (pt) | Compressor de caracol e processo para formar o mesmo | |
| IT1283646B1 (it) | Processo di preparazione di perfluoropolieteri | |
| BR9711718A (pt) | Processo para a co-produ-Æo de 6-aminocapro-nitrila e hexametileno-diamina | |
| PT909270E (pt) | Processo para a preparacao de 2,4-dihidroxipiridina e de 2,4-dihidroxi-3-nitropiridina | |
| BR9300739A (pt) | Processo hidrometalurgico para a obtencao de tantalo e niobio | |
| BR9602983A (pt) | Gel e processo para sua preparação | |
| BR9704600A (pt) | Processo e aparelho para laminado | |
| BR9601294A (pt) | Composto e processo para preparação do mesmo | |
| BR9408530A (pt) | Intermediário e processo para preparação | |
| BR9505700A (pt) | Processo para e preparação contínua de isocianatos orgânicos | |
| BR9301448A (pt) | Composicao e processo para sua preparacao | |
| BR9400338A (pt) | Processo para preparação de 1,1,1,2-tetrafluoro-2-cloroetano e de pentafluoretano | |
| BR9801205A (pt) | Processo e produto | |
| PT827693E (pt) | Produto de guarnicao para pastelaria-biscoiteria-confeitaria processo de fabrico e produto composto guarnecido | |
| BR9711578A (pt) | Lubrificante para hipercompressor e processo de obten-Æo | |
| PT915874E (pt) | Processo de preparacao de valaciclovir e intermediarios relevantes | |
| PT803576E (pt) | Processo para a preparacao de lipstatina e de tetra-hidrolipstatina | |
| BR9401483A (pt) | Composto e processo para sua preparação |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| FC | Decision: refusal |